Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) EPS (Basic): 2023-2025

Historic EPS (Basic) for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Sep 2025 value amounting to -$0.61.

  • NewAmsterdam Pharma Co N.V's EPS (Basic) fell 238.89% to -$0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.05, marking a year-over-year increase of 8.89%. This contributed to the annual value of -$2.56 for FY2024, which is 19.07% down from last year.
  • NewAmsterdam Pharma Co N.V's EPS (Basic) amounted to -$0.61 in Q3 2025, which was down 306.67% from -$0.15 recorded in Q2 2025.
  • In the past 5 years, NewAmsterdam Pharma Co N.V's EPS (Basic) ranged from a high of -$0.15 in Q2 2025 and a low of -$1.06 during Q1 2024.
  • In the last 3 years, NewAmsterdam Pharma Co N.V's EPS (Basic) had a median value of -$0.51 in 2023 and averaged -$0.53.
  • Per our database at Business Quant, NewAmsterdam Pharma Co N.V's EPS (Basic) surged by 68.42% in 2024 and then plummeted by 238.89% in 2025.
  • Over the past 3 years, NewAmsterdam Pharma Co N.V's EPS (Basic) (Quarterly) stood at -$0.60 in 2023, then crashed by 58.33% to -$0.95 in 2024, then crashed by 238.89% to -$0.61 in 2025.
  • Its last three reported values are -$0.61 in Q3 2025, -$0.15 for Q2 2025, and -$0.34 during Q1 2025.